The transcription factor USF1 is a recognized breast cancer oncogene that can promote Epithelial‐mesenchymal transition (EMT) via transforming growth factor β1 (TGF‐β1) overexpression leading to stimulation of TGF‐β1/Smad signaling.38 This evidence concerns the gene USF1 and breast carcinoma.